167 related articles for article (PubMed ID: 32521866)
1. Efficacy of neoadjuvant chemotherapy combined with intraperitoneal hyperthermic chemotherapy in advanced ovarian cancer.
Xu Z; Ge X; Zhang T; Shi Y; Sun M
J BUON; 2020; 25(2):772-778. PubMed ID: 32521866
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal hyperthermic perfusion chemotherapy of patients with chemotherapy-resistant peritoneal disseminated ovarian cancer.
Hager ED; Dziambor H; Höhmann D; Mühe N; Strama H
Int J Gynecol Cancer; 2001; 11 Suppl 1():57-63. PubMed ID: 11489005
[TBL] [Abstract][Full Text] [Related]
3. Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer.
Ryu KS; Kim JH; Ko HS; Kim JW; Ahn WS; Park YG; Kim SJ; Lee JM
Gynecol Oncol; 2004 Aug; 94(2):325-32. PubMed ID: 15297169
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy combined with laparoscopic cytoreductive surgery in patients with advanced ovarian cancer.
Wen A; Zhao L; Luo L; Du C; Luo X
J BUON; 2021; 26(4):1306-1312. PubMed ID: 34564985
[TBL] [Abstract][Full Text] [Related]
5. Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial.
Beeharry MK; Ni ZT; Yang ZY; Zheng YN; Feng RH; Liu WT; Yan C; Yao XX; Li C; Yan M; Zhu ZG
BMC Cancer; 2020 Mar; 20(1):224. PubMed ID: 32183736
[TBL] [Abstract][Full Text] [Related]
6. Treatment of ovarian cancer with paclitaxel- or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery.
Bae JH; Lee JM; Ryu KS; Lee YS; Park YG; Hur SY; Ahn WS; Namkoong SE
Gynecol Oncol; 2007 Jul; 106(1):193-200. PubMed ID: 17466362
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of intraperitoneal continuous hyperthermic chemotherapy as consolidation therapy in patients with advanced epithelial ovarian cancer: a long-term follow-up.
Yoshida Y; Sasaki H; Kurokawa T; Kawahara K; Shukunami K; Katayama K; Yamaguchi A; Kotsuji F
Oncol Rep; 2005 Jan; 13(1):121-5. PubMed ID: 15583812
[TBL] [Abstract][Full Text] [Related]
8. Preliminary results of neoadjuvant chemotherapy with paclitaxel and cisplatin in patients with advanced epithelial ovarian cancer who are inadequate for optimum primary surgery.
Lee SJ; Kim BG; Lee JW; Park CS; Lee JH; Bae DS
J Obstet Gynaecol Res; 2006 Feb; 32(1):99-106. PubMed ID: 16445534
[TBL] [Abstract][Full Text] [Related]
9. Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with primary or secondary cytoreductive surgery in the treatment of advanced epithelial ovarian cancer.
Manzanedo I; Pereira F; Pérez-Viejo E; Serrano Á; Hernández-García M; Martínez-Torres B; Rihuete-Caro C; Calzas J; Cueto M
Minerva Ginecol; 2017 Apr; 69(2):119-127. PubMed ID: 27415829
[TBL] [Abstract][Full Text] [Related]
10. Reduction of cycles of neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian or primary peritoneal cancer (ROCOCO): study protocol for a phase III randomized controlled trial.
Park SJ; Shim SH; Ji YI; Kwon SH; Lee EJ; Lee M; Chang SJ; Park S; Kim SY; Lee SJ; Kim JW; Roh JW; Lee SH; Song T; Kim HS
BMC Cancer; 2020 May; 20(1):385. PubMed ID: 32375688
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal hyperthermic chemotherapy using carboplatin: a phase I analysis in ovarian carcinoma.
Lentz SS; Miller BE; Kucera GL; Levine EA
Gynecol Oncol; 2007 Jul; 106(1):207-10. PubMed ID: 17498782
[TBL] [Abstract][Full Text] [Related]
12. Hyperthermic intraperitoneal chemotherapy in conjunction with surgery for the treatment of recurrent ovarian carcinoma.
Helm CW; Randall-Whitis L; Martin RS; Metzinger DS; Gordinier ME; Parker LP; Edwards RP
Gynecol Oncol; 2007 Apr; 105(1):90-6. PubMed ID: 17173957
[TBL] [Abstract][Full Text] [Related]
13. Impact of increased utilization of neoadjuvant chemotherapy on survival in patients with advanced ovarian cancer: experience from a comprehensive cancer center.
Lee YJ; Chung YS; Lee JY; Nam EJ; Kim SW; Kim S; Kim YT
J Gynecol Oncol; 2018 Jul; 29(4):e63. PubMed ID: 29770632
[TBL] [Abstract][Full Text] [Related]
14. [Impact of neoadjuvant chemotherapy on the survival of patients with stage IIIc and IV epithelial ovarian cancer].
Yan X; An N; Jiang GQ; Gao M; Gao YN
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):298-301. PubMed ID: 18788637
[TBL] [Abstract][Full Text] [Related]
15. Preoperative bevacizumab does not increase complications following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
King BH; Baumgartner JM; Kelly KJ; Marmor RA; Lowy AM; Veerapong J
PLoS One; 2020; 15(12):e0243252. PubMed ID: 33270763
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of cytoreductive surgery combined with intrapleural perfusion of hyperthermic chemotherapy in advanced lung adenocarcinoma with pleural dissemination.
Yi E; Kim D; Cho S; Kim K; Jheon S
J Thorac Dis; 2016 Jul; 8(7):1550-60. PubMed ID: 27499943
[TBL] [Abstract][Full Text] [Related]
17. Cytologic assessment before and after intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis.
Loggie BW; Fleming RA; Geisinger KR
Acta Cytol; 1996; 40(6):1154-8. PubMed ID: 8960022
[TBL] [Abstract][Full Text] [Related]
18. Does neoadjuvant chemotherapy plus cytoreductive surgery improve survival rates in patients with advanced epithelial ovarian cancer compared with cytoreductive surgery alone?
Solmaz U; Mat E; Dereli ML; Turan V; Peker N; Tosun G; Dogan A; Adiyeke M; Ozdemir A; Gungorduk K; Sanci M; Yildirim Y
J BUON; 2015; 20(3):847-54. PubMed ID: 26214639
[TBL] [Abstract][Full Text] [Related]
19. A Single-Center, Retrospective Study of Bevacizumab-Containing Neoadjuvant Chemotherapy followed by Interval Debulking Surgery for Ovarian Cancer.
Park J; Eoh KJ; Nam EJ; Kim S; Kim SW; Kim YT; Lee JY
Yonsei Med J; 2020 Apr; 61(4):284-290. PubMed ID: 32233170
[TBL] [Abstract][Full Text] [Related]
20. Peritonectomy and hyperthermic chemotherapy in patients with advanced or recurrent ephitelial ovarian cancer: a single center cohort study.
Massari R; Barone M; Basilico R; Carella C; Colasante A; De Tursi M; Filippone A; Guetti L; Mani A
Minerva Chir; 2014 Feb; 69(1):17-26. PubMed ID: 24675243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
